Eximo Medical developed a proprietary single-use hybrid laser catheter platform designed for the precise and safe removal of material in minimally invasive vascular procedures, including lead extraction and the treatment of peripheral artery disease (PAD). Based on this technology, the company developed the B-Laser atherectomy system, which received FDA 510(k) clearance for the treatment of PAD.

In 2019, Eximo Medical was acquired by AngioDynamics, a U.S.-based medical technology company focused on vascular and oncology solutions.